Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C7H8NO3.Na |
| Molecular Weight | 177.1331 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].C[C-]1OC(=O)N(CC=C)C1=O
InChI
InChIKey=QXGBKVKAWTZKOL-UHFFFAOYSA-N
InChI=1S/C7H8NO3.Na/c1-3-4-8-6(9)5(2)11-7(8)10;/h3H,1,4H2,2H3;/q-1;+1
Allomethadione is an anticonvulsant. It was used for the treatment of epilepsy. Allomethadione appears to have the advantage over tridione (another anticonvulsant) in not producing ataxia or gastric irritation. Photophobia is common in patients taking tridione but allomethadione did not produce photophobia. The drug causes renal damage. The compound has been marketed in Europe.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
91810501
Created by
admin on Sat Dec 16 11:02:41 GMT 2023 , Edited by admin on Sat Dec 16 11:02:41 GMT 2023
|
PRIMARY | |||
|
6058-46-4
Created by
admin on Sat Dec 16 11:02:41 GMT 2023 , Edited by admin on Sat Dec 16 11:02:41 GMT 2023
|
PRIMARY | |||
|
DTXSID50412194
Created by
admin on Sat Dec 16 11:02:41 GMT 2023 , Edited by admin on Sat Dec 16 11:02:41 GMT 2023
|
PRIMARY | |||
|
X358SB601N
Created by
admin on Sat Dec 16 11:02:41 GMT 2023 , Edited by admin on Sat Dec 16 11:02:41 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
